CVC Capital Partners’s $703 Million Acquisition of Theramex

Latham & Watkins advised CVC Capital Partners on CVC Fund VI’s acquisition of Teva Pharmaceutical Industries Ltd’s international women’s health assets. The new company, called Theramex,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now